Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dutton report is out
Reply New Message
Prev Message Back To Forum Threaded View Next Message

And they're still at the same $0.55 target...but they can cut and paste with the best of them...IMO Dutton has no effect whatsoever on our PPS movement and ability to attract new investors.

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply